BioLife Solutions
BLFS
132 hedge funds and large institutions have $915M invested in BioLife Solutions in 2021 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 37 increasing their positions, 44 reducing their positions, and 23 closing their positions.
67% more call options, than puts
Call options by funds: $4.37M | Put options by funds: $2.61M
22% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 23
3.62% more ownership
Funds ownership: 74.02% → 77.63% (+3.6%)
3% more funds holding
Funds holding: 128 → 132 (+4)
5% less capital invested
Capital invested by funds: $967M → $915M (-$52.1M)
16% less repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 44
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCM
Geneva Capital Management
Milwaukee,
Wisconsin
|
+$40.8M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$15.4M |
| 3 |
PCM
Palisade Capital Management
Fort Lee,
New Jersey
|
+$15M |
| 4 |
Millennium Management
New York
|
+$13.9M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
-$21.5M |
| 2 |
LSCM
Light Street Capital Management
Palo Alto,
California
|
-$10.6M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$8.06M |
| 4 |
ZCM
Ziegler Capital Management
Chicago,
Illinois
|
-$7.98M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$7.49M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CAAS
151
Capital Asset Advisory Services
Williamston,
Michigan
| – | -$7K | -182 | Closed |
|
152
Rockefeller Capital Management
New York
| – | -$1K | -33 | Closed |
|
|
HI
153
Harbour Investments
Madison,
Wisconsin
| – | +$237 | +6 | New |
|
BLFS Hedge Fund Activity: Q1 2021 in Review
132 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q1 2021, worth a combined $915M — down 5.4% from $967M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new BLFS positions and 23 closed out — a net gain of 5 holders — while 37 added to existing stakes and 44 trimmed.
The largest buyer was Geneva Capital Management, opening a new position worth an estimated $40.8M. The largest seller was Royce & Associates, cutting an estimated $21.5M.
- 132 institutional investors held BioLife Solutions (BLFS) as of Q1 2021, up from 128 in Q4 2020.
- Funds reported $915M of BioLife Solutions stock for Q1 2021, down 5.4% quarter-over-quarter.
- 28 funds opened new BioLife Solutions positions in Q1 2021 and 23 closed out, a net change of +5 holders.
- The largest BioLife Solutions buyer in Q1 2021 was Geneva Capital Management, an estimated $40.8M added.
- The largest BioLife Solutions seller in Q1 2021 was Royce & Associates, an estimated $21.5M sold.
Based on aggregated 13F filings for Q1 2021.